Mineralys Therapeutics Inc (MLYS) USD0.0001
1.03%- This stock can be held in a
Stocks and Shares ISASell:$12.27
Buy:$12.33
Change:
$0.51
(4.31%)
$0.51
(4.31%)Market closed | Prices delayed by at least 15 minutes
Sell:$12.27
Buy:$12.33
Change:$0.51
(4.31%)
$0.51
(4.31%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 11 November 2024 | David Malcom RodmanOther Level A | Sell Option/Award related | 5,026 | $15.00 | $75,398.04 | 140,991 |
| 6 November 2024 | David Malcom RodmanOther Level A | Sell Option/Award related | 25,482 | $15.03 | $383,065.81 | 135,974 |
| 11 October 2024 | Jon CongletonCEO | Sell Option/Award related | 15,271 | $13.52 | $206,433.38 | 895,941 |
| 11 October 2024 | Adam Scott LevyCFO | Sell Option/Award related | 10,757 | $13.57 | $146,003.69 | 236,854 |
| 24 July 2024 | CATALYS PACIFIC FUND LPVenture Capital | Sell Regular sell transaction (market) | 550,000 | $13.05 | $7,177,500.00 | 8,644,579 |
| 16 July 2024 | David Malcom RodmanOther Level A | Sell Option/Award related | 525 | $15.00 | $7,875.58 | 102,873 |
| 11 July 2024 | Jon CongletonCEO | Sell Option/Award related | 15,746 | $13.34 | $210,075.26 | 911,212 |
| 11 July 2024 | Adam Scott LevyCFO | Sell Option/Award related | 10,757 | $13.14 | $141,394.31 | 247,611 |
| 20 June 2024 | Jon CongletonCEO | Sell Regular sell transaction (market) | 14,940 | $11.73 | $175,237.24 | 926,958 |
| 18 June 2024 | Jon CongletonCEO | Sell Regular sell transaction (market) | 16,607 | $11.99 | $199,073.09 | 941,898 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 February 2024 | RA CAPITAL MANAGEMENT LPInvestment Management Company | Buy Regular purchase transaction | 1,672,508 | $13.50 | $22,578,858.00 | 2,983,755 |
| 12 February 2024 | SAMSARA BIOCAPITAL GP LLCVenture Capital | Buy Regular purchase transaction | 555,555 | $13.50 | $7,499,992.50 | 5,074,916 |
| 12 February 2024 | RA CAPITAL MANAGEMENT LPInvestment Management Company | Buy Regular purchase transaction | 549,755 | $13.50 | $7,421,142.75 | 549,755 |
| 24 July 2024 | CATALYS PACIFIC FUND LPVenture Capital | Sell Regular sell transaction (market) | 550,000 | $13.05 | $7,177,500.00 | 8,644,579 |
| 11 June 2024 | Adam Scott LevyCFO | Sell Option/Award related | 96,815 | $12.94 | $1,252,718.33 | 255,462 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.